Rocket Fuel
Advanced Search
Print    Email
Decrease (-) Restore Default Increase (+)
Find a Physician

Chronic Myeloid Leukemia Clinical Trials

Please check with your doctor or call 1-855-HCH-HOPE to find out if you qualify for any of these studies.

Trial  #

Trial Sub-type

Title

CAMN107A US37

A phase II randomized, multicenter study of treatment-free remission in chronic myeloid leukemia in chronic phase (CML-CP) patients who achieve and sustain MR4.5 after
switching to nilotinib (Tasigna).

A-13884-000
Sponsor:
Evidera
New.jpg

myeloproliferative neoplasms (MPN), most notably primary myelofibrosis (PMF), polycythemia vera (PV), and essential thrombocythemia (ET)

Qualitative Assessment of the Modified Myeloproliferative Neoplasms Symptom Assessment Form Total Symptom Score (MPN-SAF TSS) in an Electronic Format

  Holy Cross Hospital
  Holy Cross Germantown Hospital
  Icon-LinkedIn.png 
© 2014  Holy Cross Health | 1500 Forest Glen Road, Silver Spring, MD 20910 | 301-754-7000
trinity-health.org